ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Akili, Inc. (AKLI) stock surged +0.25%, trading at $0.43 on NASDAQ, up from the previous close of $0.43. The stock opened at $0.43, fluctuating between $0.43 and $0.43 in the recent session.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Employees | 68 |
Beta | 1.73 |
Sales or Revenue | $1.68M |
5Y Sales Change% | -0.916% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Healthcare Information Services |